2-[2-[2-(Methylamino)ethoxy]ethoxy]acetic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-[2-[2-(Methylamino)ethoxy]ethoxy]acetic acid
• 化学式: C₇H₁₅NO₄
• 分子量: 177.2
• InChiKey: WUIZFHDAQGKOIW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.2
• 重原子数：
  12
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  67.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Separation material comprising phosphoryl choline derivatives
  申请人：Pentracor GmbH

  公开号：EP2957563A1

  公开（公告）日：2015-12-23

  The present invention provides phosphoryl choline derivatives of general formula (I), which are suitable to be immobilized on a solid support to provide a separation material, which bind with both high affinity and high specificity to a protein, more specifically to C-reactive protein and anti-phosphoryl choline antibodies. Said separation materials are particularly useful in the extracorporeal removal of C-reactive protein and anti-phosphoryl choline antibodies from a biological fluid of a patient for prophylaxis and/or treatment of immune dysfunctions and cardiovascular diseases. Also claimed is a device containing a column that comprises separation material made from formula (I) wherein L is a linker as defined in the claims; X is selected from: -SH, -NHR3, -C=CH, -CH=CH2, -N3, -CHO. Also claimed is a separation material of general formula (II): wherein A is a solid support; Y is a group obtainable from the reactive group X.

  本发明提供了一般式（I）的磷酸胆碱衍生物，适合固定在固体支架上，以提供分离材料，其具有与蛋白质高亲和力和高特异性结合的能力，更具体地结合到C-反应蛋白和抗磷酸胆碱抗体。该分离材料在从患者的生物液中外体清除C-反应蛋白和抗磷酸胆碱抗体，以预防和/或治疗免疫功能障碍和心血管疾病方面特别有用。还声明了一种包含由公式（I）制成的分离材料的柱子的装置，其中L是如权利要求中定义的连接剂;X选自：-SH，-NHR3，-C = CH，-CH = CH2，-N3，-CHO。还声明了一种一般式（II）的分离材料：其中A是固体支架; Y是从反应基团X获得的基团。
• Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
  申请人：Von Wronski Mathew A.

  公开号：US20120315220A1

  公开（公告）日：2012-12-13

  The present invention provides compounds for targeting endothelial cells, tumor cells or other cells that express the NP-1 receptor, compositions containing the same and methods for their use. Additionally, the present invention includes diagnostic, therapeutic and radiotherapeutic compositions useful for visualization, therapy or radiotherapy.

  本发明提供了用于靶向内皮细胞、肿瘤细胞或其他表达NP-1受体的细胞的化合物，以及含有这些化合物的组合物和使用它们的方法。此外，本发明还包括用于可视化、治疗或放射治疗的诊断、治疗和放射治疗组合物。
• COMPOUNDS FOR TARGETING ENDOTHELIAL CELLS, COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THEIR USE
  申请人：Von Wronski Mathew A.

  公开号：US20110262366A1

  公开（公告）日：2011-10-27

  The present invention provides compounds for targeting endothelial cells, tumor cells or other cells that express the NP-1 receptor, compositions containing the same and methods for their use. Additionally, the present invention includes diagnostic, therapeutic and radiotherapeutic compositions useful for visualization, therapy or radiotherapy.

  本发明提供了用于靶向内皮细胞、肿瘤细胞或其他表达NP-1受体的细胞的化合物，包含这些化合物的组合物以及它们的使用方法。此外，本发明还包括用于可视化、治疗或放射治疗的诊断、治疗和放射治疗组合物。
• SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVES
  申请人：Pentracor GmbH

  公开号：EP3041852A1

  公开（公告）日：2016-07-13
• NUCLEAR TRANSPORT AGENT AND METHOD FOR PRODUCING SAID AGENT
  申请人：Siebenkotten Gregor

  公开号：US20090253206A1

  公开（公告）日：2009-10-08

  The present invention relates to a transport agent for transporting nucleic acids into eukaryotic cells and a method for producing said agent. The invention further concerns methods for transporting nucleic acids into eukaryotic cells using the transport agent according to the invention. The present invention provides an alternative transport agent and a method which are effective to allow an efficient transport of nucleic acids into eukaryotic cells. The transport agent comprises a complex forming moiety that is capable of forming complexes with at least one nucleic acid molecule and condensing said nucleic acid molecule, and at least one nuclear localization moiety comprising at least one nuclear localization signal and having an approximately neutral net charge.